Katherine A Janeway MD
Associate Professor, Pediatrics-Children's Hospital, Harvard Medical School
Join to View Full Profile
Dana Farber Cancer Institute44 Binney StreetBoston, MA 02115
Phone+1 617-632-4994
Dr. Janeway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2000 - 2004
Harvard Medical SchoolClass of 2000
Certifications & Licensure
ME State Medical License Current
MA State Medical License 2003 - 2026
RI State Medical License 2022 - 2026
VT State Medical License 2022 - 2026
CT State Medical License 2022 - 2025
NH State Medical License 2024 - 2024
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- iCAT for Recurrent/Refractory/HR Solid Tumors Start of enrollment: 2012 Aug 01
- The ICat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
- Olaparib with Ceralasertib in Recurrent Osteosarcoma Start of enrollment: 2020 Nov 24
Publications & Presentations
PubMed
- Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination.Katie A Greenzang, Kathleen E Montgomery, Adam DuVall, Michael E Roth, Mark Krailo
Journal of the National Cancer Institute. 2025-03-31 - Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.Riaz Gillani, David S Shulman, Natalie J DelRocco, Kelly Klega, Ruxu Han
Medrxiv. 2025-01-20 - Rare germline structural variants increase risk for pediatric solid tumors.Riaz Gillani, Ryan L Collins, Jett Crowdis, Amanda Garza, Jill K Jones
Science. 2025-01-03
Journal Articles
- Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer PopulationKhanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation
- Integrated Genetic and Pharmacologic Interrogation of Rare CancersAndrew L Hong, Katherine A Janeway, Brian D Crompton, Kimberly Stegmaier, Levi A Garraway, Alanna J Church, Stuart L Schreiber, William C Hahn, Nature
Lectures
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Refining the Genomic Landscape of Pediatric Cancers2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Chemotherapy and radiation therapy in the management of osteosarcomaJaneway KA, Goorin AM, Maki R
http://www.uptodate.com/contents/chemotherapy-and-radiation-therapy-in-the-management-of-osteosarcom
UpToDate, Wolters Kluwer Health - 2012-12-06
Press Mentions
Peptomyc Announces the Beginning of a Phase 2 Clinical Trial of OMO-103 in Advanced OsteosarcomaJanuary 16th, 2025- Genomic ‘Fingerprinting’ Yields Better Treatments for Pediatric Solid CancersJune 24th, 2022
- Study Shows That Genomic Tumor Profiling of Pediatric Tumors Can Enhance Clinical CareJune 23rd, 2022
- Join now to see all
Grant Support
- Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adultsBROAD INSTITUTE, INC.2020–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
